Wachtell-Led Swiss Pharma Co. Raises $340M In Offering
Swiss biopharmaceutical company Idorsia Ltd., guided in the U.S. by Wachtell Lipton Rosen & Katz, said Wednesday it raised CHF330 million (about $340 million) in an upsized share offering whose proceeds will...To view the full article, register now.
Already a subscriber? Click here to view full article